Designing antigens for the prevention and treatment of autoimmune diseases
Research output: Contribution to journal › Review article
Colleges, School and Institutes
Antigen-specific immunotherapy is considered the holy-grail for treatment of autoimmune diseases. However, unlike the unattainable myth of Arthurian legend, effective antigen-specific immunotherapy is now being realised through clinical trials in patients. This review describes the various approaches being taken, how antigens are being designed for therapy and carriers created for their delivery. A critical assessment is made concerning the need for such carrier systems.
|Number of pages||8|
|Journal||Current Opinion in Chemical Engineering|
|Early online date||28 Dec 2017|
|Publication status||Published - 1 Mar 2018|